OLYMPUS Investor Day 2018 (2)

from the beginning

Enhancement of Infection PreventionActivities

Presenter：

Yoshio Tashiro
Executive Officer, Medical Reprocessing Strategy

Disclaimers

Medical Device

Environmental Changes at Endoscope Industries

Waning from Regulatory Authorities regarding Infection risks with Duodenoscope

Duodenoscope

Our Approaches to Improve Safety

1. Provide Comprehensive Solutions

Develop Easier Handling Endoscopes/Cleaning Adaptors

Product Development for New Duodenoscope

Items for Reprocessing Efficacy Evaluation and Drying/Storage

Reprocessing Process Management (Software base system)

3. Supporting Tools and Training Program Enhancement

3.Enhancement of Reprocessing Tests Capabilities

4. Enhance Communication with Stakeholders

Enhancement of Organization

Summary

@

Business Reforms and Innovation Technologies

Presenter：

Haruo Ogawa
Chief Technology Officer and Head of R&D Group

Disclaimers

Agenda

1. Progress of BPR: R&D Productivity Improvement

1. Progress of BPR: R&D Productivity Improvement

1. Progress of BPR: Surgical Energy Devices Examples of New Product Development

1. Progress of BPR: Surgical Energy Devices - Examples of New Product Development

2. Innovation activities to react our risks

2. Innovation activities to react our risks

A N S E R S B E Y O N D S I G H T

The Goals for

Three Frameworks

Future of Surgery

Future of Surgery

Future of Surgery

Future of Surgery

Future of Surgery

Future of Surgery

Future of Surgery

Future of Endoscopic Examination

Number of Cancer Cases in Japan

Numbers of Endoscopic Examinations and Procedures

Numbers of Endoscopic Examinations and Procedures

Technologies Used in Endoscopes

Precautions to Minimize Infection Risk when Using Duodenoscopes

Endoscope :Today and Challenge

Future workflow in endoscope examination

@

Financial Strategy

Presenter：

YasuoTakeuchi
Vice President & CFO

Disclaimers

Review of Financial Strategy -Progress at the end of March 2018 (Outlook)

Management Goals

@

Q&A